Sickle cell disease

No longer a single gene disorder

David H K Chui, George J Dover

Research output: Contribution to journalArticle

Abstract

Patients who are homozygous for the sickle hemoglobin mutation can present with remarkably different clinical courses, varying from death in childhood, to recurrent painful vasoocclusive crises and multiple organ damage in adults, to being relatively well even until old age. Increasing numbers of genetic loci have now been identified that can modulate sickle cell disease phenotype, from nucleotide motifs within the β-globin gene cluster, to genes located on different chromosomes. With recent success of the human genome project, it is anticipated that many more genetic modifiers of sickle cell disease will be discovered that can lead to the development of more effective therapeutic approaches. The multigenic origin of the variable phenotype in sickle cell disease will serve as a paradigm for the study of variation in phenotypes of all single gene disorders in man.

Original languageEnglish (US)
Pages (from-to)22-27
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume13
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Sickle Cell Anemia
Phenotype
Genes
Human Genome Project
Sickle Hemoglobin
Nucleotide Motifs
Genetic Loci
Globins
Multigene Family
Chromosomes
Mutation
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Sickle cell disease : No longer a single gene disorder. / Chui, David H K; Dover, George J.

In: Current Opinion in Pediatrics, Vol. 13, No. 1, 2001, p. 22-27.

Research output: Contribution to journalArticle

@article{7e1c88cd727a49c7899e86cc66c7aaf9,
title = "Sickle cell disease: No longer a single gene disorder",
abstract = "Patients who are homozygous for the sickle hemoglobin mutation can present with remarkably different clinical courses, varying from death in childhood, to recurrent painful vasoocclusive crises and multiple organ damage in adults, to being relatively well even until old age. Increasing numbers of genetic loci have now been identified that can modulate sickle cell disease phenotype, from nucleotide motifs within the β-globin gene cluster, to genes located on different chromosomes. With recent success of the human genome project, it is anticipated that many more genetic modifiers of sickle cell disease will be discovered that can lead to the development of more effective therapeutic approaches. The multigenic origin of the variable phenotype in sickle cell disease will serve as a paradigm for the study of variation in phenotypes of all single gene disorders in man.",
author = "Chui, {David H K} and Dover, {George J}",
year = "2001",
doi = "10.1097/00008480-200102000-00004",
language = "English (US)",
volume = "13",
pages = "22--27",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Sickle cell disease

T2 - No longer a single gene disorder

AU - Chui, David H K

AU - Dover, George J

PY - 2001

Y1 - 2001

N2 - Patients who are homozygous for the sickle hemoglobin mutation can present with remarkably different clinical courses, varying from death in childhood, to recurrent painful vasoocclusive crises and multiple organ damage in adults, to being relatively well even until old age. Increasing numbers of genetic loci have now been identified that can modulate sickle cell disease phenotype, from nucleotide motifs within the β-globin gene cluster, to genes located on different chromosomes. With recent success of the human genome project, it is anticipated that many more genetic modifiers of sickle cell disease will be discovered that can lead to the development of more effective therapeutic approaches. The multigenic origin of the variable phenotype in sickle cell disease will serve as a paradigm for the study of variation in phenotypes of all single gene disorders in man.

AB - Patients who are homozygous for the sickle hemoglobin mutation can present with remarkably different clinical courses, varying from death in childhood, to recurrent painful vasoocclusive crises and multiple organ damage in adults, to being relatively well even until old age. Increasing numbers of genetic loci have now been identified that can modulate sickle cell disease phenotype, from nucleotide motifs within the β-globin gene cluster, to genes located on different chromosomes. With recent success of the human genome project, it is anticipated that many more genetic modifiers of sickle cell disease will be discovered that can lead to the development of more effective therapeutic approaches. The multigenic origin of the variable phenotype in sickle cell disease will serve as a paradigm for the study of variation in phenotypes of all single gene disorders in man.

UR - http://www.scopus.com/inward/record.url?scp=0035139122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035139122&partnerID=8YFLogxK

U2 - 10.1097/00008480-200102000-00004

DO - 10.1097/00008480-200102000-00004

M3 - Article

VL - 13

SP - 22

EP - 27

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 1

ER -